Half-year report · Q2

Period2024-09-01 → 2025-02-28
Filed2025-04-11
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 41
MetricValuePeriodScopeSource row
Operating income−¥996m2024-09-01 → 2025-02-28StandaloneOperating income
Operating income−¥810m2023-09-01 → 2024-02-29StandaloneOperating income
Ordinary income−¥975m2024-09-01 → 2025-02-28StandaloneOrdinary income
Ordinary income−¥1.8bn2023-09-01 → 2024-08-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥801m2023-09-01 → 2024-02-29StandaloneOrdinary income
Profit before tax−¥975m2024-09-01 → 2025-02-28StandaloneIncome before income taxes
Profit before tax−¥801m2023-09-01 → 2024-02-29StandaloneIncome before income taxes
Net income−¥976m2024-09-01 → 2025-02-28StandaloneProfit loss
Net income−¥1.8bn2023-09-01 → 2024-08-31StandaloneNet income loss (5-year summary)
Net income−¥803m2023-09-01 → 2024-02-29StandaloneProfit loss
Total assets¥3.5bnat 2025-02-28StandaloneAssets
Total assets¥4.6bnat 2024-08-31StandaloneAssets
Total assets¥3.9bnat 2024-02-29StandaloneTotal assets (5-year summary)
Total liabilities¥205mat 2025-02-28StandaloneLiabilities
Total liabilities¥471mat 2024-08-31StandaloneLiabilities
Net assets / equity¥3.2bnat 2025-02-28StandaloneNet assets
Net assets / equity¥4.2bnat 2024-08-31StandaloneNet assets
Net assets / equity¥3.7bnat 2024-02-29StandaloneNet assets (5-year summary)
Cash and deposits¥3.3bnat 2025-02-28StandaloneCash and deposits
Cash and deposits¥4.3bnat 2024-08-31StandaloneCash and deposits
Cash & equivalents¥3.3bnat 2025-02-28StandaloneCash and cash equivalents
Cash & equivalents¥4.3bnat 2024-08-31StandaloneCash and cash equivalents
Cash & equivalents¥3.7bnat 2024-02-29StandaloneCash and cash equivalents
Cash & equivalents¥4.8bnat 2023-08-31dStandaloneCash and cash equivalents
Operating cash flow−¥1.1bn2024-09-01 → 2025-02-28StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.9bn2023-09-01 → 2024-08-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.1bn2023-09-01 → 2024-02-29StandaloneNet cash provided by used in operating activities
Investing cash flow−¥667,0002024-09-01 → 2025-02-28StandaloneNet cash provided by used in investment activities
Investing cash flow−¥11m2023-09-01 → 2024-08-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥178,0002023-09-01 → 2024-02-29StandaloneNet cash provided by used in investment activities
Financing cash flow¥62m2024-09-01 → 2025-02-28StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.5bn2023-09-01 → 2024-08-31StandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-14.312024-09-01 → 2025-02-28StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-31.112023-09-01 → 2024-08-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-14.222023-09-01 → 2024-02-29StandaloneBasic earnings loss per share (5-year summary)
Equity ratio94.0%at 2025-02-28StandaloneEquity to asset ratio (5-year summary)
Equity ratio89.8%at 2024-08-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio94.1%at 2024-02-29StandaloneEquity to asset ratio (5-year summary)
Shares issued68,988,800at 2025-02-28StandaloneTotal number of issued shares (5-year summary)
Shares issued67,678,800at 2024-08-31StandaloneTotal number of issued shares (5-year summary)
Shares issued56,443,800at 2024-02-29StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 328
ItemContextValueUnit
Address major shareholdersCurrentQuarterInstant_No10MajorShareholdersMember
Original text (Japanese)東京都中央区京橋三丁目1番1号
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsOtherMember
Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式であり、単元株式数は100株であります。
Description issued shares voting rightsCurrentQuarterInstant_SharesLessThanOneUnitMember-
Treasury shares etc (text)FilingDateInstantText · Plus
Information about officers (text)FilingDateInstantText · Plus
Regulations in accordance with which financial statements have been prepared financial informationCurrentYTDDurationText · Plus
Type1 semi annual financial statements financial informationCurrentYTDDurationText · Plus
Note on independent audit financial informationCurrentYTDDurationText · Plus
Description of fact that consolidated financial statements have not been prepared financial informationCurrentYTDDuration
Original text (Japanese) 当社は子会社がありませんので、中間連結財務諸表は作成しておりません。
Quarterly balance sheet (text)CurrentYTDDurationText · Plus
Year to quarter end statement of income (text)CurrentYTDDurationText · Plus
Quarterly statement of cash flows (text)CurrentYTDDurationText · Plus
Notes regarding research and development expenses (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Major components of selling general and administrative expenses (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Notes segment information etc quarterly financial statements (text)CurrentYTDDurationText · Plus
Description of fact that companys business comprises single segmentPrior1YTDDuration_NonConsolidatedMember
Original text (Japanese) 当社の事業セグメントは、医薬品事業のみの単一セグメントであるため、記載を省略しております。
Description of fact that companys business comprises single segmentCurrentYTDDuration_NonConsolidatedMember
Original text (Japanese) 当社の事業セグメントは、医薬品事業のみの単一セグメントであるため、記載を省略しております。
Notes revenue recognition quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly financial statements (text)CurrentYTDDurationText · Plus
Other information financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2024-08-31pass rounding
balance sheet identitynon_consolidated 2025-02-28pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2024-08-31pass
statement vs summary · net assetsnon_consolidated 2025-02-28pass
statement vs summary · operating cash flownon_consolidated 2023-09-01/2024-02-29pass
statement vs summary · operating cash flownon_consolidated 2024-09-01/2025-02-28pass
statement vs summary · total assetsnon_consolidated 2024-08-31pass
statement vs summary · total assetsnon_consolidated 2025-02-28pass